Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease
A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low ...
Jun 27, 2022
0
75